HMG-1/Y Regulation of NOS2 Expression in Endotoxemia
HMG-1/Y 在内毒素血症中 NOS2 表达的调节
基本信息
- 批准号:7227530
- 负责人:
- 金额:$ 12.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AT Rich SequenceAddressAll SitesAnimalsBacteriaBindingBinding SitesBlood PressureBlood VesselsCarboxypeptidaseClinicalCo-ImmunoprecipitationsComplexConditionConsensusCultured CellsDNADNA BindingDNA SequenceDNA-Binding ProteinsDevelopmentDiseaseDisruptionDistamycinDominant-Negative MutationEducational process of instructingElectrophoretic Mobility Shift AssayEnd PointEndotoxemiaGene ExpressionGene ProteinsHistologyHospitalsIRF1 geneIn VitroInfectionInflammatory ResponseInterferon Type IIInterferonsInterleukinsInvestigationKnowledgeLaboratoriesLeadLipopolysaccharidesMaintenanceMeasurementMolecular and Cellular BiologyMorbidity - disease rateMusNOS2A geneNitric OxideNitric Oxide SynthaseNuclearNuclear ProteinNuclear ProteinsNumbersOrganOutcomePatientsPhysiologyPlayProcessProductionPromoter RegionsProtein OverexpressionRegulationResearchResearch ActivityResearch PersonnelResourcesRoleSepsisSiteSmooth Muscle MyocytesStructureTestingTissuesToxinTrainingTrans-ActivatorsTransfectionTransgenic MiceUp-RegulationWomanWorkcis acting elementcytokineexperiencegene inductionhuman NOS2A proteinimmunoregulationimprovedin vitro Assayin vivoinhibitor/antagonistmacrophagemortalitynovelprogramspromoterresearch studyresponseskillstranscription factortransgene expression
项目摘要
DESCRIPTION (provided by applicant): Sepsis is a disease process representing the systemic response to severe infection and causes high morbidity and mortality. In a subset of sepsis patients, toxins such as lipopolysaccharide (LPS) are released by bacteria and activate an inflammatory response, including the release of cytokines such as interferon (IFN)-gamma. The inducible form of nitric oxide synthase (NOS2) plays an important role in endotoxemia through overproduction of nitric oxide (NO), which has been implicated in a number of pathophysiologic mechanisms of endotoxemia. The objectives of the proposal are: (a) to gain skills and knowledge in the investigation of the role of the architectural transcription factor high mobility group-I/Y (HMG-I/Y) in NOS2 expression under conditions of endotoxemia; (b) to gain experience in teaching others; and (c) to achieve the necessary expertise to lead an independent research group. This training at Brigham and Women's Hospital will incorporate the participation in several structured research activities leading to scientific independence. The laboratory is equipped with the resources required for research in cellular and molecular biology, animal physiology, and histology. The overall hypothesis of our proposed work is that HMG-I/Y facilitates the LPS/IFN-gamma synergistic induction of NOS2 and may be an important modulator of NO production in endotoxemia. In AIM 1 we will determine whether HMG-I/Y interacts with the transcription factors important for LPS/IFN-gamma induction of NOS2 using in vitro assays. In AIM 2, we will determine whether altering HMG-I/Y binding to DNA in vitro and in vivo alters NOS2 gene expression and animal survival under conditions of endotoxemia. In AIM 3, we will elucidate the role of HMG-I/Y and its effect on NOS2 expression and animal survival during endotoxemia using a transgenic mouse expressing a dominant-negative form of HMG-I/Y in the vasculature. These experiments will allow us to determine the role of HMG-I/Y in regulating NOS2 expression during endotoxemia and may reveal a novel target for improving outcomes from sepsis.
描述(由申请方提供):脓毒症是一种疾病过程,代表对严重感染的全身反应,并导致高发病率和死亡率。在败血症患者的子集中,毒素如脂多糖(LPS)由细菌释放并激活炎症反应,包括释放细胞因子如干扰素(IFN)-γ。诱导型一氧化氮合酶(inducible form of nitric oxide synthase,NOS 2)通过过量产生一氧化氮(nitric oxide,NO)在内毒素血症中起重要作用,参与了内毒素血症的多种病理生理机制。该提案的目的是:(a)获得技能和知识,在调查的作用,建筑转录因子高迁移率组-I/Y(HMG-I/Y)在NOS 2表达条件下的内毒素血症;(B)获得教学经验;和(c)实现必要的专业知识,领导一个独立的研究小组。在布里格姆妇女医院的培训将包括参与几项结构化的研究活动,从而实现科学独立。该实验室配备了细胞和分子生物学,动物生理学和组织学研究所需的资源。我们提出的工作的总体假设是,HMG-I/Y促进LPS/IFN-γ协同诱导NOS 2,并可能是内毒素血症中NO产生的重要调节剂。在AIM 1中,我们将使用体外测定来确定HMG-I/Y是否与对于LPS/IFN-γ诱导NOS 2重要的转录因子相互作用。在AIM 2中,我们将确定在体外和体内改变HMG-I/Y与DNA的结合是否会改变NOS 2基因表达和内毒素血症条件下动物的存活率。在AIM 3中,我们将阐明HMG-I/Y的作用及其对NOS 2表达和内毒素血症期间动物存活的影响,使用在血管系统中表达显性阴性形式HMG-I/Y的转基因小鼠。这些实验将使我们能够确定HMG-I/Y在内毒素血症期间调节NOS 2表达的作用,并可能揭示改善脓毒症结局的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca M Baron其他文献
Rebecca M Baron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca M Baron', 18)}}的其他基金
A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS
吸入 CO 治疗脓毒症引起的 ARDS 的 1b 期研究
- 批准号:
10698000 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS
吸入 CO 治疗脓毒症引起的 ARDS 的 1b 期研究
- 批准号:
10274795 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
Therapeutic modulation of zinc for lung injury and mechanobiology
锌对肺损伤和机械生物学的治疗调节
- 批准号:
10378503 - 财政年份:2019
- 资助金额:
$ 12.85万 - 项目类别:
Biomarkers of Interstitial Lung Abnormalities Predict Poor Outcomes in ARDS.
间质性肺异常的生物标志物预示 ARDS 的不良结局。
- 批准号:
10021700 - 财政年份:2019
- 资助金额:
$ 12.85万 - 项目类别:
Therapeutic modulation of zinc for lung injury and mechanobiology
锌对肺损伤和机械生物学的治疗调节
- 批准号:
9894841 - 财政年份:2019
- 资助金额:
$ 12.85万 - 项目类别:
The Inflammasome: A Novel Biomarker in ALI/ARDS
炎症小体:ALI/ARDS 的新型生物标志物
- 批准号:
8267826 - 财政年份:2012
- 资助金额:
$ 12.85万 - 项目类别:
The Inflammasome: A Novel Biomarker in ALI/ARDS
炎症小体:ALI/ARDS 的新型生物标志物
- 批准号:
8466370 - 财政年份:2012
- 资助金额:
$ 12.85万 - 项目类别:
The Inflammasome: A Novel Biomarker in ALI/ARDS
炎症小体:ALI/ARDS 的新型生物标志物
- 批准号:
8661275 - 财政年份:2012
- 资助金额:
$ 12.85万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 12.85万 - 项目类别:
Research Grant